The CD79α (HM47/A9) antibody is effective in distinguishing between primary hepatocellular carcinoma and primary intrahepatic cholangiocarcinoma

Author：    

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.5, Iss.4, 2013-01, pp. : 1195-1198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A case report

By        

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 273-276

Spandidos Publications

Access to resources Recommend Favorite

Synchronous double primary cancer intrahepatic cholangiocarcinoma with bone metastases and thyroid carcinoma: A case report

By          

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3799-3802

Spandidos Publications

Access to resources Recommend Favorite

Study of the correlation between H-ras mutation and primary hepatocellular carcinoma

By          

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 779-782

Spandidos Publications

Access to resources Recommend Favorite

Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma: A Western Experience

By Portolani Nazario  

Annals of Surgical Oncology, Vol. 15, Iss. 7, 2008-07 ,pp. : 1880-1890

Springer Publishing Company

Access to resources Recommend Favorite

Concomitant early gallbladder carcinoma with primary sarcomatoid hepatocellular carcinoma: A case report

By              

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1965-1967

Spandidos Publications

Access to resources Recommend Favorite